Goldline Pharmaceutical share news and announcements
BSE: 544759Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.98.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29 Cr3,537th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 9 Jun 2026
- 7.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 9 Jun 2026
- 2.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in May 2026
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 9 Jun 2026
- 28.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 9 Jun 2026
- 0.64
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,000
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Goldline Pharmaceutical half-yearly results
The board met on 9 Jun 2026 to consider audited results and half yearly results
Notice filed 2 Jun 2026
Goldline Pharmaceutical annual reports, presentations and earnings calls
The company's own documents, latest first.Goldline Pharmaceutical financials, year by year
Annual reports1
Goldline Pharmaceutical share news and announcements
21 announcements, routine notices left out, newest first.
Sep 2026
Aug 2026
31 Aug · Meeting
6 Aug · Meeting
Jul 2026
Jun 2026
2 Jun · Board meeting
Meeting on 9 Jun 2026: audited results and half yearly results
May 2026
19 May · Listing of Equity Shares of Goldline Pharmaceutical Ltd
Trading Members of the Exchange are hereby informed that effective from May 19, 2026, the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings ....
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 15 Jul 2026Board or managers changedup 0.46%+0.2 pts vs Nifty 500market median 0.0% · five sessions +5.6% (+4.9 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 10 Jun 2026Board or managers changedup 13.44%+14.1 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+0.7 pts vs Nifty 500) · The announcement (opens in a new tab)